Current perspectives of bacteriophage therapy for multidrug- resistant wound infections

Phage therapy shows promise against antimicrobial-resistant wound infections. Although clinical outcomes are encouraging, its widespread use is limited by legal, technical, and awareness barriers. Future success in the treatment of wound infections with phage therapy will depend on the development of standardized protocols, rapid diagnostics tools, and large-scale clinical trials - challenges that also apply broadly to phage therapy in other clinical contexts. Phage therapy, especially in local applications, aligns well with the principles of personalized medicine and may become a valuable component of modern wound care within the next decade.